The pharmacological treatment of dyslipidemia

C. A. Dujovne, William Harris

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

This review discusses the drugs and other substances used to treat abnormal blood lipid levels (dyslipidemia) in order to retard arteriosclerosis. The relationship between dyslipidemia and morbidity and/or mortality from arteriosclerotic cardiovascular disease (ASCVD) has long been established.

Original languageEnglish (US)
Pages (from-to)265-288
Number of pages24
JournalAnnual Review of Pharmacology and Toxicology
Volume29
StatePublished - 1989
Externally publishedYes

Fingerprint

Dyslipidemias
Blood
Pharmacology
Lipids
Arteriosclerosis
Pharmaceutical Preparations
Cardiovascular Diseases
Morbidity
Mortality

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

The pharmacological treatment of dyslipidemia. / Dujovne, C. A.; Harris, William.

In: Annual Review of Pharmacology and Toxicology, Vol. 29, 1989, p. 265-288.

Research output: Contribution to journalArticle

Dujovne, C. A. ; Harris, William. / The pharmacological treatment of dyslipidemia. In: Annual Review of Pharmacology and Toxicology. 1989 ; Vol. 29. pp. 265-288.
@article{0f17b45cd2554d19a5c6adc01279c2d6,
title = "The pharmacological treatment of dyslipidemia",
abstract = "This review discusses the drugs and other substances used to treat abnormal blood lipid levels (dyslipidemia) in order to retard arteriosclerosis. The relationship between dyslipidemia and morbidity and/or mortality from arteriosclerotic cardiovascular disease (ASCVD) has long been established.",
author = "Dujovne, {C. A.} and William Harris",
year = "1989",
language = "English (US)",
volume = "29",
pages = "265--288",
journal = "Annual Review of Pharmacology and Toxicology",
issn = "0362-1642",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - The pharmacological treatment of dyslipidemia

AU - Dujovne, C. A.

AU - Harris, William

PY - 1989

Y1 - 1989

N2 - This review discusses the drugs and other substances used to treat abnormal blood lipid levels (dyslipidemia) in order to retard arteriosclerosis. The relationship between dyslipidemia and morbidity and/or mortality from arteriosclerotic cardiovascular disease (ASCVD) has long been established.

AB - This review discusses the drugs and other substances used to treat abnormal blood lipid levels (dyslipidemia) in order to retard arteriosclerosis. The relationship between dyslipidemia and morbidity and/or mortality from arteriosclerotic cardiovascular disease (ASCVD) has long been established.

UR - http://www.scopus.com/inward/record.url?scp=0024506065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024506065&partnerID=8YFLogxK

M3 - Article

VL - 29

SP - 265

EP - 288

JO - Annual Review of Pharmacology and Toxicology

JF - Annual Review of Pharmacology and Toxicology

SN - 0362-1642

ER -